• Hypoxia and Immunometabolism: Mechanisms in Tumor Microenvir

  2026-07-15

  This review synthesizes cutting-edge insights into how hypoxia-driven metabolic reprogramming and immunometabolic adaptations shape the tumor microenvironment (TME). By detailing the interplay of oxygen deprivation, nutrient competition, and immune cell function, the study highlights potential metabolic targets for tumor therapy and underscores experimental considerations for modeling these processes.

• Ferrostatin-1 (Fer-1): Precision Ferroptosis Assays & Workfl

  2026-07-15

  Ferrostatin-1 (Fer-1) empowers researchers to selectively inhibit ferroptosis in disease models where oxidative lipid damage is central. This guide translates the latest mechanistic findings into actionable workflows and troubleshooting strategies, making Fer-1 from APExBIO a go-to tool for robust, reproducible results.

• Cholesterol Impedes Lipid Nanoparticle Trafficking in Cells

  2026-07-14

  This study reveals that increasing cholesterol content in lipid nanoparticles (LNPs) significantly hinders their intracellular trafficking by causing peripheral endosomal trapping, ultimately reducing nucleic acid delivery efficiency. The work provides mechanistic insights critical for optimizing LNP formulations in gene therapy and nucleic acid delivery applications.

• Strategic Deployment of EPZ-6438: Translating EZH2 Inhibitio

  2026-07-14

  This article provides a thought-leadership perspective for translational researchers on leveraging EPZ-6438, a potent EZH2 inhibitor, to dissect and therapeutically target the PRC2 pathway in aggressive cancers. Integrating mechanistic insights, experimental protocols, competitive benchmarking, and clinical strategy, the piece synthesizes recent findings—including combinatorial approaches in resistant melanoma and advanced guidance for research design. Distinct from standard product summaries, this article uniquely bridges molecular rationale with actionable translational roadmaps.

• Dextrose (D-glucose): Precision Tool for Tumor Immunometabol

  2026-07-13

  Explore how Dextrose (D-glucose) enables advanced research into tumor immunometabolism and hypoxic adaptation. This article uniquely connects metabolic reprogramming, assay optimization, and translational impact, grounded in the latest scientific insights.

• Decoding Aneugenic Mechanisms: Molecular Profiling via Flow

  2026-07-13

  Bernacki et al. introduce a mechanistically tiered assay that distinguishes between tubulin destabilization, stabilization, and mitotic kinase inhibition as drivers of chemical-induced aneugenicity. Their flow cytometric workflow, validated with 27 reference compounds, enables robust molecular target classification relevant to genotoxicity and advanced antifungal research.

• Dextrose (D-glucose): Powering Hypoxia and Immunometabolic A

  2026-07-12

  Dextrose (D-glucose) empowers researchers to dissect hypoxia-driven metabolic reprogramming and immune cell function with precision and reproducibility. This guide delivers actionable workflows, advanced troubleshooting, and data-backed enhancements tailored for cutting-edge glucose metabolism research.

• Bestatin (Ubenimex): Decoding Aminopeptidase Signaling in Pl

  2026-07-10

  Explore the unique capabilities of Bestatin (Ubenimex) as a selective aminopeptidase inhibitor for advanced apoptosis assays and multidrug resistance research. This article uncovers novel applications in plant signaling and cancer workflows, with insights not found in typical inhibitor reviews.

• HDAC3 Modulates Ferroptosis via NRF2–GPX4 in Colorectal Canc

  2026-07-09

  This study identifies histone deacetylase 3 (HDAC3) as a central epigenetic suppressor of ferroptosis in colorectal cancer, acting through the NRF2–GPX4 signaling axis. The findings provide mechanistic insights and highlight new therapeutic opportunities to sensitize tumors to ferroptosis-inducing treatments.

• LAMP1 Regulates CXCL10-CXCR3 Axis in Macrophage Polarization

  2026-07-09

  This study uncovers how LAMP1 modulates macrophage fate via the CXCL10-CXCR3 axis, revealing that macrophage polarization outcomes depend on inflammatory context and LAMP1 expression. Importantly, CXCR3 antagonism with AMG 487 reverses polarization direction and attenuates acute lung injury, providing a mechanistic framework for targeted intervention in inflammation.

• Hypoxia and Immunometabolism in Tumor Microenvironments

  2026-07-08

  This review dissects how hypoxia-driven metabolic reprogramming and immune cell adaptations shape the tumor microenvironment (TME), influencing tumor progression and immune evasion. The analysis provides mechanistic insights into the interplay between oxygen deprivation, glucose metabolism, and immunosuppressive dynamics, guiding the development of metabolism-based cancer therapies.

• Hypoxia-Driven Immunometabolic Reprogramming in Tumor Microe

  2026-07-08

  This review synthesizes recent advances in understanding how hypoxia and immunometabolism interact to shape the tumor microenvironment (TME). By detailing mechanisms of metabolic reprogramming and immune evasion under hypoxic stress, it provides a mechanistic foundation for metabolism-based cancer therapies and highlights challenges for translational research.

• Optimizing Cancer Cell Assays with Ganetespib (STA-9090)

  2026-07-07

  This article delivers scenario-driven, evidence-based guidance for leveraging Ganetespib (STA-9090, SKU A4385) in cell viability and cytotoxicity assays. It addresses common laboratory challenges—such as reproducibility, sensitivity, and vendor selection—using real-world Q&A, protocol tips, and literature-backed data. Researchers will find actionable best practices and reliable performance insights tailored to advanced cancer research workflows.

• IL-1β/NF-κB Drives ACE2 in Macrophage SARS-CoV-2 Susceptibil

  2026-07-07

  Lee et al. reveal that IL-1β-driven NF-κB activation upregulates ACE2 expression in macrophages, enabling productive SARS-CoV-2 infection in a novel humanized ACE2 mouse model. This study provides mechanistic insight into inflammation-mediated viral entry and highlights nuanced differences in COVID-19 disease models with implications for host resilience research.

• Ferrostatin-1 in Ferroptosis Assays: Workflows, Applications

  2026-07-06

  Ferrostatin-1 (Fer-1) stands at the forefront of mechanistic and applied ferroptosis inhibition, enabling reproducible oxidative lipid damage assays in cancer and neurodegeneration. This article delivers stepwise workflows, troubleshooting strategies, and context drawn from breakthrough redox modulation studies.

15996 records 1/1067 page Next 12345 下5页 Last page